Cibiem Obtains $10,000,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0c82a78c-9fcc-4d5c-92e9-b847b87f73d1&Preview=1 - Date
10/18/2012 - Company Name
Cibiem - Mailing Address
134 West 26th Street New York, NY 10001 - Company Description
Cibiem is a medical device company leveraging its proprietary, minimally invasive, catheter-based approach focused on Carotid Body Modulation (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes and renal failure. - Website
http://www.cibiem.com - Transaction Type
Venture Equity - Transaction Amount
$10,000,000 - Transaction Round
Series A - Proceeds Purposes
Cibiem is launching out of the medical device incubator Coridea, and will use the money to develop its catheter-based treatment of diseases such as hypertension, heart failure, diabetes and renal failure. - M&A Terms
- Venture Investor
SV Life Sciences - Venture Investor
Third Rock Ventures
